L366-0862 Screening compound: 3-(2-benzenesulfonamido-4-methoxy-1,3-benzothiazol-6-yl)-1-[(oxolan-2-yl)methyl]urea

L366-0862 Screening compound: 3-(2-benzenesulfonamido-4-methoxy-1,3-benzothiazol-6-yl)-1-[(oxolan-2-yl)methyl]urea
L366-0862 Screening compound: 3-(2-benzenesulfonamido-4-methoxy-1,3-benzothiazol-6-yl)-1-[(oxolan-2-yl)methyl]urea alternative view

Chemical Structure Depiction of ChemDiv screening compound L366-0862
3-(2-benzenesulfonamido-4-methoxy-1,3-benzothiazol-6-yl)-1-[(oxolan-2-yl)methyl]urea

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

L366-0862

Molecular Formula

C20H22N4O5S2 (C20 H22 N4 O5 S2)

Compound Name

3-(2-benzenesulfonamido-4-methoxy-1,3-benzothiazol-6-yl)-1-[(oxolan-2-yl)methyl]urea

IUPAC name

3-(2-benzenesulfonamido-4-methoxy-13-benzothiazol-6-yl)-1-[(oxolan-2-yl)methyl]urea

SMILES

COc1cc(NC(NCC2OCCC2)=O)cc2c1nc(NS(c1ccccc1)(=O)=O)s2

InChI

InChI=1S/C20H22N4O5S2/c1-28-16-10-13(22-19(25)21-12-14-6-5-9-29-14)11-17-18(16)23-20(30-17)24-31(26,27)15-7-3-2-4-8-15/h2-4,7-8,10-11,14H,5-6,9,12H2,1H3,(H,23,24)(H2,21,22,25)/t14-/m1/s1

InChI Key

ORYSWXZLSIANET-CQSZACIVSA-N

MDL Number (MFCD)

MFCD15125418

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

462.55

Hydrogen Bond Acceptors Count

9.00

Hydrogen Bond Donors Count

3.00

Rotatable Bond Count

9.00

Number of Nitrogen and Oxygen Atoms

9

Partition Coefficient, logP

2.808

Distribution Coefficient, logD

2.586

Water Solubility, LogSw

-3.57

Polar Surface Area

101.330

Acid Dissociation Constant (pKa)

7.58

Base Dissociation Constant (pKb)

1.66

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

30.00

L366-0862 in Drug Discovery

Included in Screening Libraries

3D-Pharmacophore Based Diversity Library (49813 compounds)

Allosteric Kinases Inhibitors Library (23117 compounds)

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

Aurora A-B Kinases Targeted Library (9426 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Female
  • Congenital
  • Skin
  • Cancer
  • Digestive system
  • Male
  • Female
  • Hemic and lymphatic
Targets:
  • Kinases
  • Kinases

References: we are preparing a list of scientific research reports with L366-0862 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound L366-0862?
Check Price and Availability of L366-0862, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of L366-0862 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for L366-0862
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for L366-0862
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of L366-0862 available by request